EX1 0.57% 87.5¢ exopharm limited

Ann: Explainer The critical bottleneck of exosome isolation, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,452 Posts.
    lightbulb Created with Sketch. 314
    I’m glad EX1 did this, an explanation in LEAP technology. For anyone that hasn’t done their homework already & where we are up to in clinical trials, & very importantly Exosomes & the manufacturing process for future Human trials, this announcement was a blessing to assist with investment research. We are just going through the process right now of clinical trials. Human trials later this year. Was about time for an ANN
 
watchlist Created with Sketch. Add EX1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.